Targeted radiation zaps advanced prostate cancer in new trial
NCT ID NCT05570994
Summary
This study is testing a new, personalized radiation treatment for men with advanced prostate cancer that has spread and is no longer responding to standard hormone-blocking drugs. The treatment uses a radioactive drug that seeks out and delivers radiation directly to prostate cancer cells. Researchers aim to find the safest and most effective dose while measuring how well it controls the cancer and impacts quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION-RESISTANT PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BC Cancer
Vancouver, British Columbia, V5Z 4E6, Canada
Conditions
Explore the condition pages connected to this study.